Evidence map›Paper›PMID 42244841›Full record

ReviewChemical science2026

Rethinking photosensitization in therapy and sun protection.

Erick L Bastos, Waleska K Martins, Rosangela Itri, Thiago T Tasso, Maurício S Baptista

Abstract readReview
In one paragraph

Review in Chemical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Erick L BastosDepartment of Fundamental Chemistry, Institute of Chemistry, University of São Paulo 05508-000 São Paulo SP Brazil elbastos@usp.br.ORCID https://orcid.org/0000-0002-0592-9455
Waleska K MartinsDepartment of Biochemistry, Institute of Chemistry, University of São Paulo 05508-000 São Paulo SP Brazil baptista@iq.usp.br.
Rosangela ItriInstituto de Física, Universidade de São Paulo 05508-090 São Paulo SP Brazil.ORCID https://orcid.org/0000-0001-9311-0804
Thiago T TassoChemistry Department, Institute of Exact Sciences, Universidade Federal de Minas Gerais 31270-901 Belo Horizonte MG Brazil.
Maurício S BaptistaDepartment of Biochemistry, Institute of Chemistry, University of São Paulo 05508-000 São Paulo SP Brazil baptista@iq.usp.br.ORCID https://orcid.org/0000-0001-7079-7666

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Light-induced tissue damage involves photosensitization. This process forms the basis of photodynamic therapy but also underlies photoaging and skin cancer development during excessive sun exposure. This review bridges these interlinked, yet rarely connected fields. We propose a unified classification distinguishing photosensitizers, photocatalysts, photoinitiators, and photocatalytic initiators based on absorber fate and downstream radical chain propagation. This framework resolves longstanding ambiguities and carries direct mechanistic consequences. Our central thesis is that subcellular localization determines the biological outcome far more than quantum yields. Membrane-bound photosensitizers permeabilize organelles orders of magnitude more efficiently than their broadly distributed counterparts, provided direct photosensitizer-lipid contact favors truncated lipid generation through Type I electron-transfer reactions rather than singlet oxygen oxidation. Organelle-specific targeting exploits this principle. Mitochondrial photodamage triggers regulated cell death through cardiolipin oxidation and cytochrome c release. Lysosomal targeting induces cathepsin release and autophagy dysfunction, often proving more effective for long-term cell killing. Dual-organelle strategies activate apoptosis, ferroptosis, and pyroptosis synergistically. These same mechanisms operate during sun exposure. Lipofuscin mediates radical chain amplification, creating a feed-forward cycle of visible light sensitivity in aging skin. Pheomelanin acts as a Type I photosensitizer generating superoxide and hydrogen peroxide under visible light, while eumelanin dissipates photon energy as heat. The amplification inherent in photoinitiated processes explains why modest light doses overwhelm antioxidant defenses, tipping redox homeostasis from eustress to distress. We translate these insights into mechanistically rational photoprotection strategies addressing visible light beyond conventional UV filters and into design principles for next-generation therapeutic photosensitizers.

Identifiers

PMID42244841
PMCPMC13232635

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.